Cingulate CING
NASDAQ CING
$5.26 +0.03 (+0.48%)
As of: Sep 22, 2026 · 11:16 AM EDT

Cingulate (CING) Common Equity (2021 - 2026)

Cingulate's (CING) quarterly Common Equity came in at $23.5 million in Q2 2026, down 90.22% on a YoY basis from $240.0 million in Q2 2025, and up 835.35% quarter-over-quarter from $2.5 million in Q4 2025.

Analysis

Cingulate (CING) Common Equity (2021 - 2026) Analysis & Trends

Cingulate (CING) has reported Common Equity for 6 consecutive years, with $23.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Common Equity fell 90.22% year-over-year to $23.5 million; the trailing twelve-month figure through Jun 2026 stood at $23.5 million (down 90.22% YoY), and the FY2025 full-year result was $2.5 million, down 98.95% from the prior year.
  • Common Equity rose to $23.5 million in Q2 2026 per CING's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $240.0 million in Q2 2025 and bottomed at -$6.9 million in Q4 2023.
  • Historically, Common Equity has averaged $19.3 million across 5 years, with a median of $3.9 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Common Equity tumbled 276.95% in 2023, then surged 12595.65% in 2024.
  • Over 5 years, Common Equity stood at $3.9 million in 2022, then sank by 276.95% to -$6.9 million in 2023, then soared by 208.53% to $7.5 million in 2024, then sank by 66.35% to $2.5 million in 2025, then surged by 835.35% to $23.5 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered $23.5 million, $2.5 million, and $3.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 84.97 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -5.94 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 106.07 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 41.95 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 85.49 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 22.32 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 80.86 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - 2.61 Bn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 5.17 Bn
10 Cingulate 72.81 Mn 72.81 Mn - 23.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.47 Mn
Dec 31, 2025 2.51 Mn
Sep 30, 2025 3.47 Mn
Jun 30, 2025 240.00 Mn
Mar 31, 2025 5.93 Mn
Dec 31, 2024 7.46 Mn
Sep 30, 2024 12.04 Mn
Jun 30, 2024 3.08 Mn
Mar 31, 2024 3.22 Mn
Dec 31, 2023 -6.87 Mn
Sep 30, 2023 -96,334.00
Jun 30, 2023 -6.10 Mn
Mar 31, 2023 81,614.00
Dec 31, 2022 3.88 Mn
Sep 30, 2022 8.37 Mn
Jun 30, 2022 12.18 Mn
Mar 31, 2022 16.02 Mn
Dec 31, 2021 20.84 Mn
Sep 30, 2021 3.08 Mn
Jun 30, 2021 1.90 Mn
API Access

Cingulate Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=CING&period=max&api_key=YOUR_API_KEY